Literature DB >> 32513850

Early Insights into Immune Responses during COVID-19.

Ashley L St John1,2,3,4, Abhay P S Rathore4.   

Abstract

Coronavirus disease-2019 (COVID-19) is caused by the newly emerged virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and was recently declared as a pandemic by the World Health Organization. In its severe form, the disease is characterized by acute respiratory distress syndrome, and there are no targeted intervention strategies to treat or prevent it. The immune response is thought to both contribute to the pathogenesis of disease and provide protection during its resolution. Thus, understanding the immune response to SARS-CoV-2 is of the utmost importance for developing and testing vaccines and therapeutics. In this review, we discuss the earliest knowledge and hypotheses of the mechanisms of immune pathology in the lung during acute infection as well at the later stages of disease resolution, recovery, and immune memory formation.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Year:  2020        PMID: 32513850     DOI: 10.4049/jimmunol.2000526

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Dynamics of CD4 T Cell and Antibody Responses in COVID-19 Patients With Different Disease Severity.

Authors:  Maximilian Koblischke; Marianna T Traugott; Iris Medits; Felicia S Spitzer; Alexander Zoufaly; Lukas Weseslindtner; Cara Simonitsch; Tamara Seitz; Wolfgang Hoepler; Elisabeth Puchhammer-Stöckl; Stephan W Aberle; Manuela Födinger; Andreas Bergthaler; Michael Kundi; Franz X Heinz; Karin Stiasny; Judith H Aberle
Journal:  Front Med (Lausanne)       Date:  2020-11-11

2.  A new diagnosis of systemic capillary leak syndrome in a patient with COVID-19.

Authors:  Carole Lacout; Juliette Rogez; Corentin Orvain; Claire Nicot; Louis Rony; Hélène Julien; Geoffrey Urbanski
Journal:  Rheumatology (Oxford)       Date:  2020-09-17       Impact factor: 7.580

3.  Pathways for bradykinin formation and interrelationship with complement as a cause of edematous lung in COVID-19 patients.

Authors:  Allen P Kaplan; Berhane Ghebrehiwet
Journal:  J Allergy Clin Immunol       Date:  2020-10-28       Impact factor: 10.793

4.  Health Disparities in COVID-19: Addressing the Role of Social Determinants of Health in Immune System Dysfunction to Turn the Tide.

Authors:  Yvonne Baumer; Nicole Farmer; Thomas A Premeaux; Gwenyth R Wallen; Tiffany M Powell-Wiley
Journal:  Front Public Health       Date:  2020-10-08

5.  Evaluating ELISA, Immunofluorescence, and Lateral Flow Assay for SARS-CoV-2 Serologic Assays.

Authors:  Moïse Michel; Amar Bouam; Sophie Edouard; Florence Fenollar; Fabrizio Di Pinto; Jean-Louis Mège; Michel Drancourt; Joana Vitte
Journal:  Front Microbiol       Date:  2020-12-11       Impact factor: 5.640

Review 6.  Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.

Authors:  Tiphanie P Vogel; Karina A Top; Christos Karatzios; David C Hilmers; Lorena I Tapia; Pamela Moceri; Lisa Giovannini-Chami; Nicholas Wood; Rebecca E Chandler; Nicola P Klein; Elizabeth P Schlaudecker; M Cecilia Poli; Eyal Muscal; Flor M Munoz
Journal:  Vaccine       Date:  2021-02-25       Impact factor: 3.641

7.  COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis.

Authors:  Masoud Dadashi; Saeedeh Khaleghnejad; Parisa Abedi Elkhichi; Mehdi Goudarzi; Hossein Goudarzi; Afsoon Taghavi; Maryam Vaezjalali; Bahareh Hajikhani
Journal:  Front Med (Lausanne)       Date:  2021-06-25

8.  Chronic spontaneous urticaria exacerbation in a patient with COVID-19: rapid and excellent response to omalizumab.

Authors:  Paulo R Criado; Roberta F J Criado; Thais P Pincelli; Thais A Yoshimoto; Gabriela G A Naufal; Beatrice M Z Abdalla
Journal:  Int J Dermatol       Date:  2020-08-17       Impact factor: 2.736

9.  Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients.

Authors:  Juanjie Tang; Supriya Ravichandran; Youri Lee; Gabrielle Grubbs; Elizabeth M Coyle; Laura Klenow; Hollie Genser; Hana Golding; Surender Khurana
Journal:  Nat Commun       Date:  2021-02-22       Impact factor: 14.919

10.  Antigenic variation of SARS-CoV-2 in response to immune pressure.

Authors:  Diego Forni; Rachele Cagliani; Chiara Pontremoli; Alessandra Mozzi; Uberto Pozzoli; Mario Clerici; Manuela Sironi
Journal:  Mol Ecol       Date:  2020-12-02       Impact factor: 6.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.